Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Manufacturers—Specialty & Generic Average | - - | - - | - - | 369,825.61 | 33,850.00 | 1,619.90 | 80,124.19 | -81.37 | 0.01 | 21.0846 | 53.63 | 0.3416 | -0.7978 | 0.00 | 0.02 | 2.4531 | - - | ||
Maximum | - - | - - | - - | 9,605,168.00 | 528,312.00 | 32,061.00 | 1,988,352.00 | 12,901.00 | 0.05 | 511.0525 | 2,720.42 | 0.9317 | 0.7155 | 0.08 | 1.46 | 35.1990 | - - | ||
Minimum | - - | - - | - - | 0.00 | 0.00 | -9,633.00 | -277,041.00 | -18,385.00 | 0.00 | -791.2164 | -853.08 | -3.9254 | -42.3731 | -0.31 | -0.90 | 0.0000 | - - | ||
Alkermes plc ALKS | 29.23 | -0.85 -2.81% | 1,494 vs. 1,674 | 4,729.00 | 350.00 | 36.00 | 12.00 | -1,306.00 | 0.2200 | 31.0625 | 0.0000 | 0.8256 | 0.1051 | 0.0294 | 0.0173 | 2.3141 | 161.00 | ||
Neurocrine Biosciences, Inc. NBIX | 127.01 | -0.16 -0.13% | 832 vs. 968 | 12,859.00 | 515.00 | 43.00 | 119.00 | -113.00 | 0.4300 | 81.2772 | 0.0000 | 0.9752 | 0.0842 | 0.0182 | 0.0125 | 2.3303 | 101.00 | ||
Catalent, Inc. CTLT | 59.25 | -0.21 -0.35% | 1,103 vs. 1,683 | 10,754.00 | 1,074.00 | -101.00 | -62.00 | -804.00 | -0.5500 | -25.4034 | 0.0000 | 0.2132 | -0.0940 | -0.0280 | -0.0102 | 1.5571 | 181.00 | ||
Lantheus Holdings, Inc. LNTH | 85.15 | 1.07 1.27% | 1,591 vs. 825 | 5,920.00 | 369.00 | 131.00 | 118.00 | 264.00 | 1.9100 | 7.8834 | 0.0000 | 0.6805 | 0.3543 | 0.1386 | 0.0716 | 4.4506 | 69.00 | ||
Amphastar Pharmaceuticals, Inc. AMPH | 47.71 | -0.86 -1.77% | 340 vs. 346 | 2,293.00 | 171.00 | 43.00 | 46.00 | 452.00 | 0.9000 | 12.1264 | 0.0000 | 0.5080 | 0.2513 | 0.0642 | 0.0274 | 1.6856 | 48.00 |